Alpha Tau Medical Ltd. (DRTS)Healthcare | Biotechnology | Jerusalem, Israel | NasdaqCM
14.64 USD
-0.17
(-1.148%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 14.85 +0.21 (1.434%) ⇧ (Aug. 28, 2026, 7:50 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:58 a.m. EDT
The immediate catalyst here is the clinical data; headlines confirm 100% response rates in trials, which has pushed the stock to its 52-week high and triggered a massive speculative bid. The options market confirms this sentiment, with traders buying calls far more aggressively than they are hedging with puts, betting on a continuation of the rally toward the $17.50 and $20.00 targets. However, this is a classic biotech binary event play, not a value investment. Fundamentally, the company is burning cash with negative free cash flow and no earnings, trading at a premium to book value despite a lack of commercial revenue. The long-term outlook remains neutral because the multi-year price trajectory shows a brutal collapse followed by a volatile recovery, leaving the business quality ambiguous without sustained commercial traction. For now, the momentum is strong enough to support a bullish short-term stance, but investors should treat this as a high-risk speculation on the next trial milestone rather than a core holding. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.196052 |
| MSTL | 0.240175 |
| AutoETS | 0.263666 |
| AutoARIMA | 0.263794 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 1.64 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.090 |
| Excess Kurtosis | -0.53 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 34.393 |
| Market Cap | 1,353,880,192 |
| Forward P/E | -27.79 |
| Beta | 1.19 |
| Website | https://www.alphatau.com |
As of Aug. 22, 2026, 4:58 a.m. EDT: Speculators are positioning aggressively for upside, evidenced by heavy open interest in out-of-the-money calls (73% of total call volume) and significant volume at strikes like $17.50 and $20.00 for later expirations. Conversely, put activity is concentrated deep in-the-money ($7.50, $10.00), suggesting a floor rather than a ceiling, while ATM put volume remains negligible compared to calls. Implied volatility is elevated on near-term puts relative to calls, indicating a fear of a sharp drop, yet the bulk of capital flow is directional bullish.
| Attribute | Value |
|---|---|
| 52 Week Change | 3.2557473 |
| Address1 | Kiryat HaMada St. 5 |
| All Time High | 20.65 |
| All Time Low | 1.75 |
| Ask | 18.5 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 464,730 |
| Average Daily Volume3 Month | 752,598 |
| Average Volume | 752,598 |
| Average Volume10Days | 464,730 |
| Beta | 1.185 |
| Bid | 14.68 |
| Bid Size | 1 |
| Book Value | 0.477 |
| City | Jerusalem |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 14.64 |
| Current Ratio | 11.091 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 14.8999 |
| Day Low | 14.45 |
| Debt To Equity | 34.393 |
| Display Name | Alpha Tau Medical |
| Earnings Timestamp End | 1,795,118,400 |
| Earnings Timestamp Start | 1,795,118,400 |
| Ebitda | -48,760,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -25.969 |
| Enterprise Value | 1,266,266,240 |
| Eps Current Year | -0.87761 |
| Eps Forward | -0.52678 |
| Eps Trailing Twelve Months | -1.04 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 12.7714 |
| Fifty Day Average Change | 1.8685999 |
| Fifty Day Average Change Percent | 0.14631127 |
| Fifty Two Week Change Percent | 325.57474 |
| Fifty Two Week High | 15.1 |
| Fifty Two Week High Change | -0.46000004 |
| Fifty Two Week High Change Percent | -0.030463578 |
| Fifty Two Week Low | 3.35 |
| Fifty Two Week Low Change | 11.290001 |
| Fifty Two Week Low Change Percent | 3.3701496 |
| Fifty Two Week Range | 3.35 - 15.1 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,615,213,800,000 |
| Float Shares | 64,101,174 |
| Forward Eps | -0.52678 |
| Forward P E | -27.791489 |
| Free Cashflow | -20,261,876 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 121 |
| Fullday Change | -0.17 |
| Fullday Change Percent | -1.14787 |
| Fullday Price | 14.85 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.30505 |
| Held Percent Institutions | 0.08941 |
| Implied Shares Outstanding | 92,478,154 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,022-03-08 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel. |
| Long Name | Alpha Tau Medical Ltd. |
| Market | us_market |
| Market Cap | 1,353,880,192 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_531816986 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -92,574,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,372,375,805 |
| Number Of Analyst Opinions | 5 |
| Open | 14.76 |
| Operating Cashflow | -12,814,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 972 3 577 4115 |
| Post Market Change | 0.21000004 |
| Post Market Change Percent | 1.4344264 |
| Post Market Price | 14.85 |
| Post Market Time | 1,787,961,022 |
| Previous Close | 14.81 |
| Price Eps Current Year | -16.68167 |
| Price Hint | 2 |
| Price To Book | 30.691824 |
| Profit Margins | 0.0 |
| Quick Ratio | 10.448 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.17 |
| Regular Market Change Percent | -1.14787 |
| Regular Market Day High | 14.8999 |
| Regular Market Day Low | 14.45 |
| Regular Market Day Range | 14.45 - 14.8999 |
| Regular Market Open | 14.76 |
| Regular Market Previous Close | 14.81 |
| Regular Market Price | 14.64 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 475,251 |
| Return On Assets | -0.25707 |
| Return On Equity | -1.41683 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 92,478,154 |
| Shares Percent Shares Out | 0.033099998 |
| Shares Short | 3,060,060 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 2,980,762 |
| Short Name | Alpha Tau Medical Ltd. |
| Short Percent Of Float | 0.0476 |
| Short Ratio | 5.25 |
| Source Interval | 15 |
| Symbol | DRTS |
| Target High Price | 17.0 |
| Target Low Price | 8.0 |
| Target Mean Price | 14.4 |
| Target Median Price | 16.0 |
| Total Cash | 100,639,000 |
| Total Cash Per Share | 1.09 |
| Total Debt | 15,152,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.04 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 8.466 |
| Two Hundred Day Average Change | 6.1740007 |
| Two Hundred Day Average Change Percent | 0.72927016 |
| Type Disp | Equity |
| Volume | 475,251 |
| Website | https://www.alphatau.com |
| Zip | 9,777,605 |